ResearcherNagoya UniversityActive in the last 2 years
Yuki Sunagawa
Matched on ORCID iD 0000-0002-3666-1607; OpenAlex author ID A5040678944. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 42
2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 6
- Three Molecular Developmental Pathways of Remnant Pancreatic Cancer After Resection: A Nationwide Project Study of Japan Pancreas Society. Co-author DOI 10.1097/sla.0000000000006444↗
- The survival in octogenarians undergoing surgery for pancreatic cancer and its association with the nutritional status. Co-author DOI 10.1007/s00595-023-02782-x↗
- Reappraisal of the current resectability criteria and optimal treatment strategies for pancreatic cancer. Co-author DOI 10.21037/jgo-24-102↗
- Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy. Co-author DOI 10.1186/s13148-021-01165-8↗
- Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07981-w↗
- Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.14138↗
Closest collaborators
The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Suguru Yamada · 5 shared papers, 2020–2024 · strength 0.81
- Paper The survival in octogenarians undergoing surgery for pancreatic cancer and its association with the nutritional status. DOI 10.1007/s00595-023-02782-x↗
- Paper Reappraisal of the current resectability criteria and optimal treatment strategies for pancreatic cancer. DOI 10.21037/jgo-24-102↗
- Paper Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduoden… DOI 10.1186/s13148-021-01165-8↗
- Akimasa Nakao · 2 shared papers, 2024 · strength 0.51
- Mitsuro Kanda · 3 shared papers, 2020–2021 · strength 0.30
- Paper Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduoden… DOI 10.1186/s13148-021-01165-8↗
- Paper Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer. DOI 10.21873/anticanres.14138↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Fuminori Sonohara · 3 shared papers, 2020–2021 · strength 0.30
- Paper Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduoden… DOI 10.1186/s13148-021-01165-8↗
- Paper Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer. DOI 10.21873/anticanres.14138↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Masamichi Hayashi · 3 shared papers, 2020–2021 · strength 0.30
- Paper Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduoden… DOI 10.1186/s13148-021-01165-8↗
- Paper Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer. DOI 10.21873/anticanres.14138↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Yasuhiro Kodera · 3 shared papers, 2020–2021 · strength 0.30
- Paper Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduoden… DOI 10.1186/s13148-021-01165-8↗
- Paper Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer. DOI 10.21873/anticanres.14138↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Tsutomu Fujii · 2 shared papers, 2020–2025 · strength 0.25
- Paper Three Molecular Developmental Pathways of Remnant Pancreatic Cancer After Resection: A Nationwide Project Study of Japa… DOI 10.1097/sla.0000000000006444↗
- Paper Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer. DOI 10.1245/s10434-019-07981-w↗
- Tamotsu Kuroki · 1 shared paper, 2025 · strength 0.16
- Hisato Igarashi · 1 shared paper, 2025 · strength 0.16
- Kenichi Hakamada · 1 shared paper, 2025 · strength 0.16
- Sohei Satoi · 1 shared paper, 2025 · strength 0.16
- Masayuki Furukawa · 1 shared paper, 2025 · strength 0.16
- Motokazu Sugimoto · 1 shared paper, 2025 · strength 0.16
- Shugo Mizuno · 1 shared paper, 2025 · strength 0.16
- Hidetoshi Eguchi · 1 shared paper, 2025 · strength 0.16
- Shuji Suzuki · 1 shared paper, 2025 · strength 0.16
- Minoru Kitago · 1 shared paper, 2025 · strength 0.16
- Hiroki Yamaue · 1 shared paper, 2025 · strength 0.16
- Tomohisa Yamamoto · 1 shared paper, 2025 · strength 0.16
- Yoshifumi Takeyama · 1 shared paper, 2025 · strength 0.16
- Akira Matsushita · 1 shared paper, 2025 · strength 0.16
- Yuichi Nagakawa · 1 shared paper, 2025 · strength 0.16
- Takahiro Akahori · 1 shared paper, 2025 · strength 0.16
- Mitsugi Shimoda · 1 shared paper, 2025 · strength 0.16
- Katsuya Hirose · 1 shared paper, 2025 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.